The lancing devices and equipment market size has grown strongly in recent years. It will grow from $3.25 billion in 2025 to $3.52 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prevalence of diabetes, expansion of self-monitoring blood glucose practices, increased availability of disposable medical devices, improvements in lancet safety designs, growth of point-of-care diagnostics.
The lancing devices and equipment market size is expected to see strong growth in the next few years. It will grow to $4.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for home diagnostics solutions, rising focus on patient comfort and compliance, expansion of chronic disease monitoring programs, growing adoption of minimally invasive sampling devices, increasing investments in personal healthcare technologies. Major trends in the forecast period include increasing adoption of single-use safety lancets, rising demand for pain-minimized sampling devices, growing use of home-based glucose monitoring, expansion of adjustable depth lancing technologies, enhanced focus on infection control.
The rising prevalence of diabetes is expected to drive the growth of the lancing devices and equipment market. Diabetes is a chronic metabolic disorder marked by elevated blood glucose levels, necessitating regular monitoring to effectively manage the condition and prevent complications such as neuropathy, cardiovascular disease, and kidney damage. The increase in diabetes cases is largely attributed to rising obesity rates, which contribute to insulin resistance and metabolic dysfunction, leading to the development of the disease. This growing prevalence boosts the demand for lancing devices and equipment, as people need safe, accurate, and user-friendly blood sampling tools for frequent glucose testing, either at home or in clinical settings. For example, in February 2025, The Guardian, a UK-based news organization, reported that a total of 12.2 million people in the United Kingdom were affected by diabetes or non-diabetic hyperglycemia, including 4.6 million diagnosed with diabetes, 1.3 million with undiagnosed diabetes, and 6.3 million with non-diabetic hyperglycemia. This represents an increase from the 12.1 million cases in 2023-2024. As a result, the rising prevalence of diabetes is fueling the growth of the lancing devices and equipment market.
Major companies operating in the lancing devices and equipment market are developing innovative products such as disposable lancing devices to offer a more convenient and comfortable blood sugar monitoring experience. Disposable lancing devices are small, portable devices that puncture the skin and collect a small blood sample for glucose testing. For example, in August 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced Accu-Chek Pico, a fully disposable lancing device designed to simplify and enhance blood sugar monitoring, particularly for older adults with diabetes. It offers multiple benefits, including ease of use, gentleness on the skin, consistent lancing depths, and full disposability. It is also compatible with various Accu-Chek blood glucose meters, ensuring ease of use for individuals with diabetes.
In October 2023, Novo Nordisk acquired Biocorp for $164.5 million. This acquisition is aimed at strengthening Novo Nordisk's investments in drug delivery systems and medical devices, aligning with their focus on diabetes care solutions. The acquisition enhances Novo Nordisk's position in the diabetes market and boosts its capabilities in developing advanced lancing devices and drug delivery systems through innovative technology integration. Biocorp, a France-based company, specializes in developing blood glucose meters, lancing devices, and insulin pumps.
Major companies operating in the lancing devices and equipment market are Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.
North America was the largest region in the global lancing devices and equipment market in 2025. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lancing devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the lancing devices and equipment market by increasing costs of imported stainless steel needles, plastics, sterilization materials, and automated assembly equipment. Manufacturers and healthcare providers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on mass-produced disposable devices. These tariffs are raising unit costs and affecting pricing strategies. However, they are also encouraging regional manufacturing, localized sourcing of components, and increased investment in automated, high-volume production facilities.
The lancing devices and equipment market research report is one of a series of new reports that provides lancing devices and equipment market statistics, including lancing devices and equipment industry global market size, regional shares, competitors with a lancing devices and equipment market share, detailed lancing devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the lancing devices and equipment industry. This lancing devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Lancing devices and equipment are medical tools designed to obtain small blood samples, typically for glucose testing in diabetic patients. These devices consist of a lancet, a small needle or blade, and a mechanism that punctures the skin, usually on the fingertip, to draw blood. Lancing devices often feature adjustable depth settings to control the penetration and minimize discomfort. They are essential for routine blood glucose monitoring and other diagnostic tests that require capillary blood samples.
The primary products in the category of lancing devices and equipment include safety lancets and standard lancets. Safety lancets are sterile, single-use devices designed for the collection of capillary blood samples. These lancing devices and equipment come in both reusable and disposable variations and are available in various penetration depths, including 0.8mm-1mm, 1.1mm-1.5mm, 1.6mm-2.0mm, and others. The end-users for these devices encompass hospitals and clinics, homecare and home diagnostics, diagnostic centers and medical institutions, research and academic laboratories, as well as various other healthcare settings.
The lancing devices and equipment market consist of sales of safety lancets and standard lancets, flake lancets And fixed depth lancet. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lancing devices and equipment market size is expected to see strong growth in the next few years. It will grow to $4.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for home diagnostics solutions, rising focus on patient comfort and compliance, expansion of chronic disease monitoring programs, growing adoption of minimally invasive sampling devices, increasing investments in personal healthcare technologies. Major trends in the forecast period include increasing adoption of single-use safety lancets, rising demand for pain-minimized sampling devices, growing use of home-based glucose monitoring, expansion of adjustable depth lancing technologies, enhanced focus on infection control.
The rising prevalence of diabetes is expected to drive the growth of the lancing devices and equipment market. Diabetes is a chronic metabolic disorder marked by elevated blood glucose levels, necessitating regular monitoring to effectively manage the condition and prevent complications such as neuropathy, cardiovascular disease, and kidney damage. The increase in diabetes cases is largely attributed to rising obesity rates, which contribute to insulin resistance and metabolic dysfunction, leading to the development of the disease. This growing prevalence boosts the demand for lancing devices and equipment, as people need safe, accurate, and user-friendly blood sampling tools for frequent glucose testing, either at home or in clinical settings. For example, in February 2025, The Guardian, a UK-based news organization, reported that a total of 12.2 million people in the United Kingdom were affected by diabetes or non-diabetic hyperglycemia, including 4.6 million diagnosed with diabetes, 1.3 million with undiagnosed diabetes, and 6.3 million with non-diabetic hyperglycemia. This represents an increase from the 12.1 million cases in 2023-2024. As a result, the rising prevalence of diabetes is fueling the growth of the lancing devices and equipment market.
Major companies operating in the lancing devices and equipment market are developing innovative products such as disposable lancing devices to offer a more convenient and comfortable blood sugar monitoring experience. Disposable lancing devices are small, portable devices that puncture the skin and collect a small blood sample for glucose testing. For example, in August 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced Accu-Chek Pico, a fully disposable lancing device designed to simplify and enhance blood sugar monitoring, particularly for older adults with diabetes. It offers multiple benefits, including ease of use, gentleness on the skin, consistent lancing depths, and full disposability. It is also compatible with various Accu-Chek blood glucose meters, ensuring ease of use for individuals with diabetes.
In October 2023, Novo Nordisk acquired Biocorp for $164.5 million. This acquisition is aimed at strengthening Novo Nordisk's investments in drug delivery systems and medical devices, aligning with their focus on diabetes care solutions. The acquisition enhances Novo Nordisk's position in the diabetes market and boosts its capabilities in developing advanced lancing devices and drug delivery systems through innovative technology integration. Biocorp, a France-based company, specializes in developing blood glucose meters, lancing devices, and insulin pumps.
Major companies operating in the lancing devices and equipment market are Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.
North America was the largest region in the global lancing devices and equipment market in 2025. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lancing devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the lancing devices and equipment market by increasing costs of imported stainless steel needles, plastics, sterilization materials, and automated assembly equipment. Manufacturers and healthcare providers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on mass-produced disposable devices. These tariffs are raising unit costs and affecting pricing strategies. However, they are also encouraging regional manufacturing, localized sourcing of components, and increased investment in automated, high-volume production facilities.
The lancing devices and equipment market research report is one of a series of new reports that provides lancing devices and equipment market statistics, including lancing devices and equipment industry global market size, regional shares, competitors with a lancing devices and equipment market share, detailed lancing devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the lancing devices and equipment industry. This lancing devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Lancing devices and equipment are medical tools designed to obtain small blood samples, typically for glucose testing in diabetic patients. These devices consist of a lancet, a small needle or blade, and a mechanism that punctures the skin, usually on the fingertip, to draw blood. Lancing devices often feature adjustable depth settings to control the penetration and minimize discomfort. They are essential for routine blood glucose monitoring and other diagnostic tests that require capillary blood samples.
The primary products in the category of lancing devices and equipment include safety lancets and standard lancets. Safety lancets are sterile, single-use devices designed for the collection of capillary blood samples. These lancing devices and equipment come in both reusable and disposable variations and are available in various penetration depths, including 0.8mm-1mm, 1.1mm-1.5mm, 1.6mm-2.0mm, and others. The end-users for these devices encompass hospitals and clinics, homecare and home diagnostics, diagnostic centers and medical institutions, research and academic laboratories, as well as various other healthcare settings.
The lancing devices and equipment market consist of sales of safety lancets and standard lancets, flake lancets And fixed depth lancet. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Lancing Devices and Equipment Market Characteristics
3. Lancing Devices and Equipment Market Supply Chain Analysis
4. Global Lancing Devices and Equipment Market Trends and Strategies
5. Lancing Devices and Equipment Market Analysis of End Use Industries
7. Global Lancing Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Lancing Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Lancing Devices and Equipment Market Segmentation
10. Lancing Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Lancing Devices and Equipment Market
12. China Lancing Devices and Equipment Market
13. India Lancing Devices and Equipment Market
14. Japan Lancing Devices and Equipment Market
15. Australia Lancing Devices and Equipment Market
16. Indonesia Lancing Devices and Equipment Market
17. South Korea Lancing Devices and Equipment Market
18. Bangladesh Lancing Devices and Equipment Market
19. Thailand Lancing Devices and Equipment Market
20. Vietnam Lancing Devices and Equipment Market
21. Malaysia Lancing Devices and Equipment Market
22. Singapore Lancing Devices and Equipment Market
23. Philippines Lancing Devices and Equipment Market
24. Hong Kong Lancing Devices and Equipment Market
25. New Zealand Lancing Devices and Equipment Market
26. Taiwan Lancing Devices and Equipment Market
27. South East Asia Lancing Devices and Equipment Market
28. Western Europe Lancing Devices and Equipment Market
29. UK Lancing Devices and Equipment Market
30. Germany Lancing Devices and Equipment Market
31. France Lancing Devices and Equipment Market
32. Italy Lancing Devices and Equipment Market
33. Spain Lancing Devices and Equipment Market
34. Austria Lancing Devices and Equipment Market
35. Belgium Lancing Devices and Equipment Market
36. Denmark Lancing Devices and Equipment Market
37. Finland Lancing Devices and Equipment Market
38. Ireland Lancing Devices and Equipment Market
39. Netherlands Lancing Devices and Equipment Market
40. Norway Lancing Devices and Equipment Market
41. Portugal Lancing Devices and Equipment Market
42. Sweden Lancing Devices and Equipment Market
42. Switzerland Lancing Devices and Equipment Market
43. Eastern Europe Lancing Devices and Equipment Market
44. Russia Lancing Devices and Equipment Market
45. Czech Republic Lancing Devices and Equipment Market
46. Poland Lancing Devices and Equipment Market
47. Romania Lancing Devices and Equipment Market
48. Ukraine Lancing Devices and Equipment Market
49. North America Lancing Devices and Equipment Market
50. USA Lancing Devices and Equipment Market
51. Canada Lancing Devices and Equipment Market
52. Mexico Lancing Devices and Equipment Market
53. South America Lancing Devices and Equipment Market
54. Brazil Lancing Devices and Equipment Market
55. Chile Lancing Devices and Equipment Market
56. Argentina Lancing Devices and Equipment Market
57. Colombia Lancing Devices and Equipment Market
58. Peru Lancing Devices and Equipment Market
59. Middle East Lancing Devices and Equipment Market
60. Saudi Arabia Lancing Devices and Equipment Market
61. Israel Lancing Devices and Equipment Market
62. Iran Lancing Devices and Equipment Market
63. Turkey Lancing Devices and Equipment Market
64. United Arab Emirates Lancing Devices and Equipment Market
65. Africa Lancing Devices and Equipment Market
66. Egypt Lancing Devices and Equipment Market
67. Nigeria Lancing Devices and Equipment Market
68. South Africa Lancing Devices and Equipment Market
70. Lancing Devices and Equipment Market Competitive Landscape and Company Profiles
71. Lancing Devices and Equipment Market Other Major and Innovative Companies
74. Lancing Devices and Equipment Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Lancing Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lancing devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lancing devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lancing devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Usage Mode: Reusable; Disposable2) By Product: Safety Lancets; Standard Lancets
3) By Penetration Depth: 0.8mm-1mm; 1.1mm- 1.5mm; 1.6mm-2.0mm; Other Penetration Depths
4) By End User: Hospitals and Clinics; Homecare and Home Diagnostics; Diagnostic Centres and Medical Institutions; Research and Academic Laboratories; Other End User
Subsegments:
1) By Reusable: Manual Reusable Lancets; Automated Reusable Lancets2) By Disposable: Pre-filled Disposable Lancets; Single-use Lancets
Companies Mentioned: Abbott laboratories; B. Braun Melsungen AG; Terumo Corporation; F. Hoffmann-La Roche AG; LifeScan Inc.; Ascensia Diabetes Care Holdings AG; Becton Dickinson and Company; Bayer AG; Medtronic plc; ARKRAY Inc.; Sanofi S.A.; Ypsomed Holding AG; Sarstedt AG & Co.; Greiner Bio-One; HTL-STREFA S.A; Guangzhou Improve Medical Instruments Co. Ltd.; UltiMed Inc.; Allison Medical Inc.; Artsana S.p.a.; Perrigo Diabetes Care; MedExel Co. Ltd.; Simple Diagnostics; Stat Medical Inc.; Trividia Health; Eli Lilly and Company; Roche Diagnostics; Terumo Corporation; LifeScan; Dynarex Corporation; Dealmed Medical Supplies LLC; Advanced Diabetic Solutions; Medline Industries Inc.; Owen Mumford; ARKRAY USA Inc.; Nipro Diagnostics Inc.; AgaMatrix Inc.; Nova Biomedical; Prodigy Diabetes Care LLC; ACON Laboratories Inc.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Lancing Devices and Equipment market report include:- Abbott laboratories
- B. Braun Melsungen AG
- Terumo Corporation
- F. Hoffmann-La Roche AG
- LifeScan Inc.
- Ascensia Diabetes Care Holdings AG
- Becton Dickinson and Company
- Bayer AG
- Medtronic plc
- ARKRAY Inc.
- Sanofi S.A.
- Ypsomed Holding AG
- Sarstedt AG & Co.
- Greiner Bio-One
- HTL-STREFA S.A
- Guangzhou Improve Medical Instruments Co. Ltd.
- UltiMed Inc.
- Allison Medical Inc.
- Artsana S.p.a.
- Perrigo Diabetes Care
- MedExel Co. Ltd.
- Simple Diagnostics
- Stat Medical Inc.
- Trividia Health
- Eli Lilly and Company
- Roche Diagnostics
- Terumo Corporation
- LifeScan
- Dynarex Corporation
- Dealmed Medical Supplies LLC
- Advanced Diabetic Solutions
- Medline Industries Inc.
- Owen Mumford
- ARKRAY USA Inc.
- Nipro Diagnostics Inc.
- AgaMatrix Inc.
- Nova Biomedical
- Prodigy Diabetes Care LLC
- ACON Laboratories Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.52 Billion |
| Forecasted Market Value ( USD | $ 4.98 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 40 |
